|Back to Back Issues Page|
Validation Risk Assessment.
July 10, 2014
|Good day from Validation Online - Alex Calling:
Customer Query: After purchasing a VRA document on line.
In the Validation Risk Assessment, Document I felt that the work was only half done. It was very well laid out and very intuitive to follow. But while I was able to determine the Risk Category and Validation extent I felt that it did not deal with any of the Business process or system risks. Is that a separate document?
From everything I had read till now it seemed that once you determine if you need to validate you then need to determine your risk with using the system and the system risks.
Some articles even talk about initiating the Risk process prior to buying the system and starting to identify the risks with the current process or old system being updated.
We are all aware that risk assessment’s come in many formats; for instance, we have on our site a fully approvable FMEA which we use ourselves for all aspects of concept development and design development; however the Validation Risk Assessment (VRA) is a very different document and was specifically designed to assess and define the appropriate scope of any validation task. As such; it is a very important document which is mandated by the FDA and regularly reviewed by them.
pit-fall(s) of using multiple event Risk Assessments (such as FMEA’s) is simply that there are not (in validation) multiple variations or answers available. At the validation stage the system / process / equipment / program has already been bought / built / written / installed and commissioned. All aspects of design / functionality / safety / operability will have been fully debated and integrated at the URS stage and reviewed and approved at the DQ stage.
Hope this explains the use and importance of the VRA.
The FMEA is it a protocol and Spreadsheet or just a spreadsheet? Is there instructions on how to use it like the VRA? Is it possible to get a preview? I will need more information in order to receive authorization to purchase it.
Any vaccine that has not been stored at a temperature of 2-8ºC as per its licensing conditions is no longer a licensed product
The Problem Requires Immediate Attention
The Regulators Are adamant Compliance is Essential.
The Patient Must Come First.
Where there is any doubt that cold chain has not been maintained, medications should not be used.
Cold Chain Validation
Cold Chain Validation requires the verification that the internal temperature throughout any transportation container, used to distribute temperature sensitive cGMP regulated product; is maintained within the acceptable temperature range mandated for the product being transported. Further to this; documented evidence of such conformance must be produced. Documented proof of conformance may be produced using two sampling data loggers to record actual container temperatures at predetermined intervals. Both the actual location of the loggers and sampling time intervals must be established through trials and then validated.
Uniformity of temperature throughout the container and the location of the history generating loggers must be both established and documented during the execution of a temperature mapping exercise. The number and location of single channel data loggers required for successful temperature mapping of a cold chain warehouse is dictated by several factors. Disruptive air flows entering or leaving the storage area, distribution of conditioned air inlet and exhausts, open doors and or windows and generally the environmental insulation of the ceiling and walls.
|Back to Back Issues Page|